Off-The-Shelf (OTS) devices for drug delivery can offer advantages to development programs in timeline and risk mitigation. The performance of OTS devices is generally well understood from previous applications. In addition, the manufacturing processes are established, and the device constituent has completed documentation in place to support a sponsor’s combination product application.